CN Stock MarketDetailed Quotes

Shenzhen Kangtai Biological Products (300601)

Watchlist
  • 12.85
  • +0.18+1.42%
Post Market Jul 16 15:00 CST
14.35BMarket Cap176.03P/E (TTM)

Shenzhen Kangtai Biological Products (300601) Income Statement

Quarterly·All
YOY yoy
Hide blank lines yoy
Currency: CNY
2026/Q1
2025/FY
2025/Q9
2025/H1
2025/Q1
2024/FY
2024/Q9
2024/H1
2024/Q1
2023/FY
2023/Q9
2023/H1
2023/Q1
2022/FY
2022/Q9
2022/H1
2022/Q1
2021/FY
2021/Q9
2021/H1
Total Operating Revenue
-2.18%631.11M
+0.81%2.67B
+2.24%2.06B
+15.81%1.39B
+42.85%645.20M
-23.75%2.65B
-18.11%2.02B
-30.54%1.20B
-39.65%451.66M
+10.14%3.48B
-3.92%2.46B
-5.32%1.73B
-14.12%748.38M
-13.55%3.16B
+7.90%2.57B
+73.72%1.83B
+214.60%871.43M
+61.51%3.65B
+67.37%2.38B
+20.95%1.05B
Operating Revenue
-2.18%631.11M
+0.81%2.67B
+2.24%2.06B
+15.81%1.39B
+42.85%645.20M
-23.75%2.65B
-18.11%2.02B
-30.54%1.20B
-39.65%451.66M
+10.14%3.48B
-3.92%2.46B
-5.32%1.73B
-14.12%748.38M
-13.55%3.16B
+7.90%2.57B
+73.72%1.83B
+214.60%871.43M
+61.51%3.65B
+67.37%2.38B
+20.95%1.05B
Other Operating Revenues
----
+36.94%12.17M
----
+34.45%3.96M
----
-18.49%8.88M
----
+161.65%2.95M
----
-61.23%10.90M
----
-82.59%1.13M
----
+1107.84%28.11M
----
+1520.31%6.47M
----
+0.38%2.33M
----
+0.87%399.25K
Total Operating Cost
+0.83%599.37M
+8.84%2.50B
+20.52%1.93B
+27.76%1.29B
+41.46%594.45M
-10.43%2.30B
-7.79%1.60B
-14.28%1.01B
-16.40%420.22M
-1.84%2.57B
-12.56%1.73B
-10.00%1.18B
-10.46%502.64M
+22.72%2.62B
+63.33%1.98B
+83.61%1.31B
+111.45%561.39M
+39.12%2.13B
+30.07%1.21B
+25.37%714.59M
Cost of Sales
+6.50%182.40M
+41.72%676.61M
+61.74%540.26M
+71.67%334.79M
+137.99%171.26M
-11.21%477.42M
-2.85%334.02M
-14.98%195.01M
-31.75%71.96M
+7.55%537.67M
+3.29%343.81M
-5.75%229.38M
-13.83%105.44M
-49.32%499.95M
-8.83%332.86M
+48.65%243.38M
+207.28%122.35M
+335.88%986.43M
+262.50%365.10M
+164.18%163.72M
Operating Tax Surcharges
+70.86%6.96M
+18.15%36.10M
+26.26%22.05M
+32.98%18.16M
+47.35%4.07M
+19.27%30.55M
+14.97%17.46M
+17.85%13.66M
-33.70%2.76M
+25.02%25.62M
-2.38%15.19M
+2.67%11.59M
-5.43%4.17M
+1.66%20.49M
+0.94%15.56M
+27.31%11.29M
+66.50%4.41M
+39.43%20.16M
+91.57%15.41M
+38.84%8.87M
Operating Expense
+11.10%231.13M
+0.80%894.39M
+3.00%691.52M
+18.48%470.24M
+30.22%208.03M
-27.95%887.25M
-20.59%671.40M
-33.46%396.90M
-38.37%159.76M
+13.36%1.23B
-4.64%845.52M
-1.75%596.44M
-10.23%259.20M
+87.87%1.09B
+81.70%886.66M
+75.70%607.04M
+138.14%288.73M
-34.17%578.24M
-15.12%487.97M
+0.19%345.51M
Administrative Expenses
-14.10%71.66M
-16.32%311.42M
-7.15%227.14M
-9.38%158.52M
+13.48%83.42M
+35.06%372.14M
+42.76%244.62M
+74.85%174.93M
+42.33%73.52M
+19.70%275.53M
-8.33%171.35M
-22.19%100.05M
-10.37%51.65M
-9.08%230.18M
+15.56%186.91M
+25.78%128.57M
+14.63%57.63M
+50.33%253.17M
+33.48%161.75M
+27.63%102.22M
Research and Development
-30.13%84.28M
+6.95%543.42M
+34.74%420.07M
+34.85%296.92M
+12.10%120.63M
+1.47%508.12M
-13.03%311.77M
-10.06%220.19M
+27.40%107.61M
-37.55%500.75M
-38.28%358.50M
-28.01%244.81M
-11.65%84.47M
+126.34%801.86M
+161.34%580.88M
+171.59%340.07M
+44.24%95.60M
+32.65%354.26M
+56.27%222.27M
+47.51%125.22M
Financial Expense
+226.05%22.93M
+65.48%42.95M
+32.70%24.28M
+26.44%14.61M
+52.54%7.03M
+1764.22%25.95M
+1067.12%18.29M
+945.74%11.55M
+301.86%4.61M
+92.63%-1.56M
+91.24%-1.89M
+92.53%-1.37M
+68.88%-2.28M
+64.24%-21.15M
+45.28%-21.60M
+40.88%-18.29M
+50.29%-7.34M
-176.44%-59.17M
-172.72%-39.47M
-278.26%-30.95M
-Interest Financial Expense
+0.02%29.50M
-4.10%119.03M
-4.52%88.87M
-7.52%58.74M
-10.03%29.49M
+9.15%124.12M
+10.96%93.08M
+14.43%63.52M
+19.27%32.78M
+4.35%113.71M
+3.65%83.88M
+3.27%55.51M
+4.74%27.48M
+99.90%108.97M
+231.74%80.93M
+2632.07%53.76M
+8394.19%26.24M
+2231.92%54.51M
+960.91%24.40M
-13.71%1.97M
-Interest Financial Income
+62.32%-8.60M
+20.75%-77.97M
+12.74%-65.60M
+13.90%-44.75M
+19.25%-22.82M
+14.91%-98.39M
+12.63%-75.17M
+8.71%-51.97M
+5.19%-28.26M
+12.82%-115.62M
+18.29%-86.04M
+23.19%-56.93M
+15.78%-29.81M
-15.41%-132.62M
-63.50%-105.30M
-122.65%-74.12M
-130.63%-35.40M
-377.57%-114.91M
-280.22%-64.40M
-215.24%-33.29M
Credit Impairment Loss
-53.04%-12.21M
-43.78%-42.38M
+8.71%-34.27M
+22.91%-27.80M
+36.86%-7.98M
-130.45%-29.48M
+3.32%-37.53M
+3.88%-36.07M
+7.93%-12.64M
+67.61%-12.79M
-52.85%-38.83M
-72.69%-37.52M
-82.63%-13.73M
-278.02%-39.48M
-258.79%-25.40M
-535.76%-21.73M
-995.81%-7.52M
+49.01%-10.45M
+63.35%-7.08M
+77.82%-3.42M
Asset Impairment Loss
+126.91%6.00M
+42.19%-133.83M
-23.08%-128.80M
-37.15%-93.67M
-6352.47%-22.31M
-94.91%-231.52M
-137.65%-104.64M
-58.19%-68.29M
+96.02%-345.73K
+86.75%-118.79M
+90.91%-44.03M
+90.38%-43.17M
+14.76%-8.70M
-478.53%-896.49M
-1680.90%-484.29M
-9032.34%-448.71M
-421.33%-10.20M
-3614.66%-154.96M
-1218.47%-27.19M
-140.70%-4.91M
Fair Value Change Income
--7.60M
+282.99%5.29M
-52.73%441.90K
-93.18%58.30K
-100.00%0.00
+618.46%1.38M
+672.60%934.77K
+3401.25%854.67K
--782.67K
-93.95%192.20K
-66.33%120.99K
-92.76%24.41K
-100.00%0.00
--3.18M
+101.27%359.36K
+101.16%337.06K
-99.15%93.63K
-100.00%0.00
---28.32M
---28.95M
Investment income
--124.34K
+224.50%1.51M
-72.08%134.48K
-79.40%99.25K
--0.00
-72.62%465.02K
-71.63%481.74K
-71.63%481.74K
----
+79.88%1.70M
+1699.78%1.70M
--1.70M
--1.47M
-96.82%944.05K
-99.83%94.35K
-100.00%0.00
----
+117.21%29.71M
+116.67%56.57M
+461.41%53.52M
Asset Deal Income
+100.00%0.00
+88.90%-934.47K
-2713.80%-365.80K
-483.69%-365.90K
-360.84%-185.22K
-525.24%-8.42M
+97.40%-13.00K
-89.10%95.36K
--71.01K
-1156.20%-1.35M
-426.13%-499.78K
+464.11%874.78K
--0.00
+370.38%127.43K
+592.16%153.25K
+280.19%155.07K
----
+109.28%27.09K
+106.84%22.14K
+73.41%-86.06K
Other Revenues
-6.18%7.38M
-59.18%40.21M
-50.04%30.62M
-55.94%24.59M
-84.47%7.86M
-42.72%98.51M
-48.20%61.28M
-41.13%55.80M
+158.80%50.63M
+131.05%171.99M
+51.87%118.30M
+123.53%94.79M
-43.76%19.56M
+8.03%74.44M
+103.83%77.89M
+24.76%42.40M
+812.73%34.79M
+141.30%68.91M
+119.20%38.21M
+168.42%33.99M
Operating Profit
+44.42%40.64M
-78.99%38.07M
-98.27%5.89M
-98.79%1.73M
-59.77%28.14M
-80.90%181.22M
-55.63%341.13M
-74.80%142.69M
-71.38%69.94M
+398.80%948.92M
+403.80%768.75M
+541.82%566.36M
-25.32%244.35M
-121.87%-317.57M
-87.25%152.59M
-77.24%88.24M
+1004.86%327.20M
+87.30%1.45B
+134.79%1.20B
+27.40%387.75M
Add:Non-operating Income
-57.43%306.43K
+3.36%4.36M
+4.86%3.98M
+13.92%3.70M
+213.88%719.86K
+313.67%4.22M
+604.08%3.79M
+760.18%3.25M
+19.44%229.34K
-84.58%1.02M
-91.14%538.80K
-92.34%378.05K
-14.42%192.00K
+259.80%6.61M
+269.70%6.08M
+237.60%4.94M
+19.72%224.35K
-65.45%1.84M
+104.70%1.64M
+128.04%1.46M
Less:Non-operating Expense
-47.34%994.38K
-108.55%-3.04M
-7.60%9.67M
-40.01%5.55M
-62.31%1.89M
+269.22%35.51M
+144.16%10.46M
+211.20%9.26M
+84.13%5.01M
-64.76%9.62M
-72.16%4.29M
-65.37%2.97M
-49.84%2.72M
+83.91%27.29M
+17.62%15.40M
-30.08%8.59M
+14572.87%5.43M
+79.19%14.84M
+72.21%13.09M
+96.92%12.28M
Gross Profit
+48.13%39.95M
-69.68%45.46M
-99.94%202.30K
-100.09%-121.92K
-58.61%26.97M
-84.05%149.94M
-56.28%334.46M
-75.75%136.69M
-73.05%65.16M
+378.00%940.32M
+433.95%765.00M
+566.45%563.76M
-24.90%241.82M
-123.50%-338.25M
-87.91%143.27M
-77.56%84.59M
+981.81%322.00M
+86.33%1.44B
+135.69%1.18B
+26.16%376.93M
Less:Income tax
+38.49%6.35M
+51.93%-24.81M
-194.80%-48.98M
-31.61%-37.72M
-58.81%4.58M
-165.32%-51.62M
-124.45%-16.61M
-153.74%-28.66M
-69.39%11.13M
+138.44%79.02M
+213.49%67.95M
+248.50%53.33M
-24.90%36.36M
-216.87%-205.54M
-140.25%-59.87M
-188.93%-35.91M
+949.59%48.41M
+88.65%175.87M
+114.25%148.77M
+3.64%40.38M
Net Profit
+50.10%33.60M
-65.13%70.27M
-85.99%49.18M
-77.26%37.60M
-58.57%22.39M
-76.60%201.55M
-49.63%351.08M
-67.61%165.35M
-73.70%54.03M
+749.02%861.30M
+243.13%697.05M
+323.58%510.43M
-24.90%205.46M
-110.50%-132.71M
-80.40%203.15M
-64.19%120.50M
+987.71%273.59M
+86.01%1.26B
+139.13%1.04B
+29.54%336.55M
Net Profit from Continuing Operations
+50.10%33.60M
-65.13%70.27M
-85.99%49.18M
-77.26%37.60M
-58.57%22.39M
-76.60%201.55M
-49.63%351.08M
-67.61%165.35M
-73.70%54.03M
+749.02%861.30M
+243.13%697.05M
+323.58%510.43M
-24.90%205.46M
-110.50%-132.71M
-80.40%203.15M
-64.19%120.50M
+987.71%273.59M
+86.01%1.26B
+139.13%1.04B
+29.54%336.55M
Less:Minority Profit
+632.99%261.05K
+42.67%-56.52K
+224.45%24.68K
+335.09%68.17K
-32.48%-48.98K
---98.57K
---19.83K
--15.67K
---36.97K
----
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
Net Profit of Parent Company Owners
+48.61%33.34M
-65.12%70.33M
-86.00%49.16M
-77.30%37.53M
-58.51%22.43M
-76.59%201.65M
-49.63%351.10M
-67.61%165.34M
-73.69%54.07M
+749.02%861.30M
+243.13%697.05M
+323.58%510.43M
-24.90%205.46M
-110.50%-132.71M
-80.40%203.15M
-64.19%120.50M
+987.71%273.59M
+86.01%1.26B
+139.13%1.04B
+29.54%336.55M
Basic EPS
+50.00%0.03
-66.67%0.06
-87.10%0.04
-80.00%0.03
-60.00%0.02
-76.62%0.18
-50.00%0.31
-67.39%0.15
-72.22%0.05
+741.67%0.77
+155.35%0.62
+165.13%0.46
-55.00%0.18
-106.49%-0.12
-84.00%0.24
-64.86%0.17
+984.01%0.40
+79.61%1.85
+129.40%1.52
+22.75%0.49
Diluted EPS
+50.00%0.03
-66.67%0.06
-87.10%0.04
-80.00%0.03
-60.00%0.02
-76.62%0.18
-50.00%0.31
-67.39%0.15
-72.22%0.05
+741.67%0.77
+155.35%0.62
+165.13%0.46
-55.00%0.18
-106.59%-0.12
-83.67%0.24
-64.34%0.17
+998.90%0.40
+80.20%1.82
+129.62%1.49
+24.39%0.49
Other Composite Income
+36.81%-35.94K
-27.35%-115.81K
+32.21%-93.37K
-76.37%-95.97K
---56.88K
---90.94K
---137.74K
---54.41K
----
----
--0.00
--0.00
----
----
----
----
----
----
----
----
Other Composite Income of Parent Company Owners
+36.81%-35.94K
-27.35%-115.81K
+32.21%-93.37K
-76.37%-95.97K
---56.88K
---90.94K
---137.74K
---54.41K
----
----
--0.00
--0.00
----
----
----
----
----
----
----
----
Total Composite Income
+50.32%33.56M
-65.18%70.16M
-86.01%49.09M
-77.31%37.50M
-58.67%22.33M
-76.61%201.46M
-49.65%350.94M
-67.62%165.30M
-73.70%54.03M
+749.02%861.30M
+243.13%697.05M
+323.58%510.43M
-24.90%205.46M
-110.50%-132.71M
-80.40%203.15M
-64.19%120.50M
+987.71%273.59M
+86.01%1.26B
+139.13%1.04B
+29.54%336.55M
Total Composite Income of Parent Company Owners
+48.83%33.30M
-65.16%70.21M
-86.02%49.06M
-77.35%37.44M
-58.61%22.38M
-76.60%201.56M
-49.65%350.96M
-67.62%165.28M
-73.69%54.07M
+749.02%861.30M
+243.13%697.05M
+323.58%510.43M
-24.90%205.46M
-110.50%-132.71M
-80.40%203.15M
-64.19%120.50M
+987.71%273.59M
+86.01%1.26B
+139.13%1.04B
+29.54%336.55M
Total Composite Income of Minority Owners
+632.99%261.05K
+42.67%-56.52K
+224.45%24.68K
+335.09%68.17K
-32.48%-48.98K
---98.57K
---19.83K
--15.67K
---36.97K
----
--0.00
--0.00
----
----
----
----
----
----
----
----
Deadline
Mar 31, 2026
Dec 31, 2025
Sep 30, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Sep 30, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Sep 30, 2023
Jun 30, 2023
Mar 31, 2023
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Accounting Standard
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
2026/Q12025/FY2025/Q92025/H12025/Q12024/FY2024/Q92024/H12024/Q12023/FY2023/Q92023/H12023/Q12022/FY2022/Q92022/H12022/Q12021/FY2021/Q92021/H1

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.